Jacobs & Co

SEC CIK: 0001055544
Latest filing: Jul 8, 2026

SEC filings (opens in a new tab)

ABT holding history

Abbott Laboratories in every 13F filed by Jacobs & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overview All 13F holders of ABT Full Q2 2026 holdings

Shares (Q2 2026): 65,437
Value: $5.94M
% of portfolio: 0.5%
Quarters held: 22; Since Q1 2021

Holdings of ABT by Jacobs & Co, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	65,437	$5.94M	0.5%	+3,404+5.5%	Added	Holders
Q1 2026	62,033	$6.37M	0.6%	+1,043+1.7%	Added	Holders
Q4 2025	60,990	$7.64M	0.7%	+251+0.4%	Added	Holders
Q3 2025	60,739	$8.13M	0.8%	+737+1.2%	Added	Holders
Q2 2025	60,002	$8.16M	0.8%	−3,133−5.0%	Reduced	Holders
Q1 2025	63,135	$8.37M	0.9%	−1,779−2.7%	Reduced	Holders
Q4 2024	64,914	$7.34M	0.7%	−1,842−2.8%	Reduced	Holders
Q3 2024	66,756	$7.61M	0.8%	−1,256−1.8%	Reduced	Holders
Q2 2024	68,012	$7.07M	0.7%	+113+0.2%	Added	Holders
Q1 2024	67,899	$7.72M	0.8%	−821−1.2%	Reduced	Holders
Q4 2023	68,720	$7.56M	0.9%	−570−0.8%	Reduced	Holders
Q3 2023	69,290	$6.71M	0.8%	−131−0.2%	Reduced	Holders
Q2 2023	69,421	$7.57M	0.9%	−1,785−2.5%	Reduced	Holders
Q1 2023	71,206	$7.21M	0.9%	−1,097−1.5%	Reduced	Holders
Q4 2022	72,303	$7.94M	1.0%	+306+0.4%	Added	Holders
Q3 2022	71,997	$6.97M	1.0%	−180−0.2%	Reduced	Holders
Q2 2022	72,177	$7.84M	1.1%	−4,934−6.4%	Reduced	Holders
Q1 2022	77,111	$9.13M	1.0%	−225−0.3%	Reduced	Holders
Q4 2021	77,336	$10.9M	1.1%	−1,390−1.8%	Reduced	Holders
Q3 2021	78,726	$9.30M	1.1%	+166+0.2%	Added	Holders
Q2 2021	78,560	$9.11M	1.1%	−3,415−4.2%	Reduced	Holders
Q1 2021	81,975	$9.82M	1.2%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.